As of June 30, 2026, TAEKYUNG CHEMICAL CO. LTD carries a market capitalization of 63.10B, placing it among publicly traded companies globally. Its enterprise value stands at 79.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 63.10B |
| Enterprise Value | 79.03B |
As of June 30, 2026, TAEKYUNG CHEMICAL CO. LTD has 11.60M shares outstanding.
| Shares Outstanding | 11.60M |
As of June 30, 2026, TAEKYUNG CHEMICAL CO. LTD trades at a trailing price-to-earnings ratio of 8.72. The price-to-sales ratio is 1.09, and the price-to-book ratio stands at 0.37.
| PE Ratio | 8.72 |
| PS Ratio | 1.09 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | 513.66 |
| P/OCF Ratio | 9.68 |
As of June 30, 2026, TAEKYUNG CHEMICAL CO. LTD trades at an EV/EBITDA multiple of 218.82 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.39 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 79.03B versus a market cap of 63.10B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 1.39 |
| EV / EBITDA | 218.82 |
As of June 30, 2026, TAEKYUNG CHEMICAL CO. LTD maintains a current ratio of 5.81, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.61, indicating elevated leverage, while an interest coverage ratio of 0.31 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.81 |
| Quick Ratio | 3.86 |
| Debt / Equity | 23.61 |
| Debt / EBITDA | 111.59 |
| Interest Coverage | 0.31 |
Over the twelve months ended June 30, 2026, TAEKYUNG CHEMICAL CO. LTD posted a return on equity (ROE) of 4.23, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 3.24, measuring how efficiently the asset base is converted into earnings. The company generates approximately 564.23M in revenue per employee across its workforce of 101.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 14.04 indicates how many times TAEKYUNG CHEMICAL CO. LTD sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 4.23 |
| Return on Assets (ROA) | 3.24 |
| Revenue Per Employee | 564.23M |
| Employee Count | 101.00 |
| Inventory Turnover | 14.04 |
Over the twelve months ended June 30, 2026, TAEKYUNG CHEMICAL CO. LTD recorded an income tax benefit of -2.97B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 4.17B, leaving 7.13B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | -2.97B |
As of the close on October 23, 2026, TAEKYUNG CHEMICAL CO. LTD's stock has declined approximately 49.61% over the past 52 weeks. The 50-day moving average sits at 5,035.60, while the 200-day moving average is 6,856.55.
| 52-Week Price Change | -49.61% |
| 50-Day Moving Average | 5,035.60 |
| 200-Day Moving Average | 6,856.55 |
Over the twelve months ended June 30, 2026, TAEKYUNG CHEMICAL CO. LTD generated 56.99B in revenue and converted that into 7.13B in net income, yielding earnings per share of 623.78. EBITDA reached 361.17M, while operating income came in at -2.22B.
| Revenue | 56.99B |
| Gross Profit | 11.32B |
| Operating Income | -2.22B |
| Pretax Income | 4.17B |
| Net Income | 7.13B |
| EBITDA | 361.17M |
| EBIT | -2.22B |
| Earnings Per Share (EPS) | 623.78 |
As of June 30, 2026, TAEKYUNG CHEMICAL CO. LTD holds 24.37B in cash and equivalents against 40.30B in total debt, resulting in a net debt position of 25.00B. Total book value stands at 170.68B, with working capital of 30.37B providing operational flexibility.
| Cash & Cash Equivalents | 24.37B |
| Total Debt | 40.30B |
| Net Debt | 25.00B |
| Equity (Book Value) | 170.68B |
| Book Value Per Share | 14,713.55 |
| Working Capital | 30.37B |
TAEKYUNG CHEMICAL CO. LTD produced 6.43B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.31B in capital expenditures, free cash flow totaled 121.13M - equivalent to 10.59 per share.
| Operating Cash Flow | 6.43B |
| Capital Expenditures | -6.31B |
| Free Cash Flow | 121.13M |
| FCF Per Share | 10.59 |
Over the twelve months ended June 30, 2026, TAEKYUNG CHEMICAL CO. LTD posted a gross margin of 19.86, reflecting its pricing power and cost economics. The operating margin of -3.90 and net profit margin of 12.52 provide insight into operational efficiency.
| Gross Margin | 19.86 |
| Operating Margin | -3.90 |
| Pretax Margin | 7.31 |
| Profit Margin | 12.52 |
| EBITDA Margin | 0.63 |
Over the twelve months ended June 30, 2026, TAEKYUNG CHEMICAL CO. LTD paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 0.19, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.16, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to TAEKYUNG CHEMICAL CO. LTD shareholders.
| Shareholder Yield | 0.16 |
| FCF Yield | 0.19 |
TAEKYUNG CHEMICAL CO. LTD's most recent stock split took place on May 13, 2002 with a 1:10 split ratio.
| Last Split Date | 5/13/2002 |
| Split Ratio | 1:10 |
As of June 30, 2026, TAEKYUNG CHEMICAL CO. LTD has an Altman Z-Score of 1.99, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.99 |
Already premium?